Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global and United States Narcotic (Opioid) Drugs Market Report & Forecast 2022-2028
1 Study Coverage1.1 Narcotic (Opioid) Drugs Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Narcotic (Opioid) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Narcotic (Opioid) Drugs Market Size for the Year 2017-2028
1.2.2 Global Narcotic (Opioid) Drugs Market Size for the Year 2017-2028
1.3 Narcotic (Opioid) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Narcotic (Opioid) Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Narcotic (Opioid) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Narcotic (Opioid) Drugs Market Dynamics
1.4.1 Narcotic (Opioid) Drugs Industry Trends
1.4.2 Narcotic (Opioid) Drugs Market Drivers
1.4.3 Narcotic (Opioid) Drugs Market Challenges
1.4.4 Narcotic (Opioid) Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Narcotic (Opioid) Drugs by Type
2.1 Narcotic (Opioid) Drugs Market Segment by Type
2.1.1 Codeine
2.1.2 Fentanyl
2.1.3 Hydrocodone
2.1.4 Hydromorphone
2.1.5 Meperidine
2.1.6 Methadone
2.1.7 Others
2.2 Global Narcotic (Opioid) Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Narcotic (Opioid) Drugs Market Size by Type (2017-2028)
2.4 United States Narcotic (Opioid) Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Narcotic (Opioid) Drugs Market Size by Type (2017-2028)
3 Narcotic (Opioid) Drugs by Application
3.1 Narcotic (Opioid) Drugs Market Segment by Application
3.1.1 Pain Relief Application
3.1.2 Anesthesia Application
3.2 Global Narcotic (Opioid) Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Narcotic (Opioid) Drugs Market Size by Application (2017-2028)
3.4 United States Narcotic (Opioid) Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Narcotic (Opioid) Drugs Market Size by Application (2017-2028)
4 Global Narcotic (Opioid) Drugs Competitor Landscape by Company
4.1 Global Narcotic (Opioid) Drugs Market Size by Company
4.1.1 Top Global Narcotic (Opioid) Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Narcotic (Opioid) Drugs Revenue by Player (2017-2022)
4.2 Global Narcotic (Opioid) Drugs Concentration Ratio (CR)
4.2.1 Narcotic (Opioid) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Narcotic (Opioid) Drugs in 2021
4.2.3 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Narcotic (Opioid) Drugs Headquarters, Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Narcotic (Opioid) Drugs Headquarters and Area Served
4.3.2 Global Narcotic (Opioid) Drugs Companies Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Narcotic (Opioid) Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Narcotic (Opioid) Drugs Market Size by Company
4.5.1 Top Narcotic (Opioid) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Narcotic (Opioid) Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Narcotic (Opioid) Drugs Market Size by Region
5.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Narcotic (Opioid) Drugs Market Size by Region (2017-2028)
5.2.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2017-2022
5.2.2 Global Narcotic (Opioid) Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Narcotic (Opioid) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Narcotic (Opioid) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Narcotic (Opioid) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Narcotic (Opioid) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Narcotic (Opioid) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Narcotic (Opioid) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Narcotic (Opioid) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Narcotic (Opioid) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
7.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Teva
7.2.1 Teva Company Details
7.2.2 Teva Business Overview
7.2.3 Teva Narcotic (Opioid) Drugs Introduction
7.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.2.5 Teva Recent Development
7.3 Purdue Pharma
7.3.1 Purdue Pharma Company Details
7.3.2 Purdue Pharma Business Overview
7.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
7.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.3.5 Purdue Pharma Recent Development
7.4 Mallinckrodt
7.4.1 Mallinckrodt Company Details
7.4.2 Mallinckrodt Business Overview
7.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
7.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.4.5 Mallinckrodt Recent Development
7.5 Amneal Pharma
7.5.1 Amneal Pharma Company Details
7.5.2 Amneal Pharma Business Overview
7.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
7.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.5.5 Amneal Pharma Recent Development
7.6 Collegium
7.6.1 Collegium Company Details
7.6.2 Collegium Business Overview
7.6.3 Collegium Narcotic (Opioid) Drugs Introduction
7.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.6.5 Collegium Recent Development
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Details
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
7.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.7.5 Johnson & Johnson Recent Development
7.8 Merck
7.8.1 Merck Company Details
7.8.2 Merck Business Overview
7.8.3 Merck Narcotic (Opioid) Drugs Introduction
7.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.8.5 Merck Recent Development
7.9 Mylan
7.9.1 Mylan Company Details
7.9.2 Mylan Business Overview
7.9.3 Mylan Narcotic (Opioid) Drugs Introduction
7.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.9.5 Mylan Recent Development
7.10 Hikma Pharmaceuticals
7.10.1 Hikma Pharmaceuticals Company Details
7.10.2 Hikma Pharmaceuticals Business Overview
7.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
7.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.10.5 Hikma Pharmaceuticals Recent Development
7.11 Sun Pharma
7.11.1 Sun Pharma Company Details
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
7.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.11.5 Sun Pharma Recent Development
7.12 Endo Pharmaceuticals
7.12.1 Endo Pharmaceuticals Company Details
7.12.2 Endo Pharmaceuticals Business Overview
7.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
7.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.12.5 Endo Pharmaceuticals Recent Development
7.13 Allergan
7.13.1 Allergan Company Details
7.13.2 Allergan Business Overview
7.13.3 Allergan Narcotic (Opioid) Drugs Introduction
7.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
7.13.5 Allergan Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Narcotic (Opioid) Drugs Market Report & Forecast 2022-2028
List of TablesTable 1. Narcotic (Opioid) Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Narcotic (Opioid) Drugs Market Trends
Table 3. Narcotic (Opioid) Drugs Market Drivers
Table 4. Narcotic (Opioid) Drugs Market Challenges
Table 5. Narcotic (Opioid) Drugs Market Restraints
Table 6. Global Narcotic (Opioid) Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Narcotic (Opioid) Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Narcotic (Opioid) Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Narcotic (Opioid) Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Narcotic (Opioid) Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Narcotic (Opioid) Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Narcotic (Opioid) Drugs Revenue Share by Player, 2017-2022
Table 13. Global Narcotic (Opioid) Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021)
Table 15. Top Players of Narcotic (Opioid) Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Narcotic (Opioid) Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Narcotic (Opioid) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Narcotic (Opioid) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Narcotic (Opioid) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Narcotic (Opioid) Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Narcotic (Opioid) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Narcotic (Opioid) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Narcotic (Opioid) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Narcotic (Opioid) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Narcotic (Opioid) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Narcotic (Opioid) Drugs Product
Table 33. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Teva Company Details
Table 36. Teva Business Overview
Table 37. Teva Narcotic (Opioid) Drugs Product
Table 38. Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 39. Teva Recent Development
Table 40. Purdue Pharma Company Details
Table 41. Purdue Pharma Business Overview
Table 42. Purdue Pharma Narcotic (Opioid) Drugs Product
Table 43. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 44. Purdue Pharma Recent Development
Table 45. Mallinckrodt Company Details
Table 46. Mallinckrodt Business Overview
Table 47. Mallinckrodt Narcotic (Opioid) Drugs Product
Table 48. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 49. Mallinckrodt Recent Development
Table 50. Amneal Pharma Company Details
Table 51. Amneal Pharma Business Overview
Table 52. Amneal Pharma Narcotic (Opioid) Drugs Product
Table 53. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 54. Amneal Pharma Recent Development
Table 55. Collegium Company Details
Table 56. Collegium Business Overview
Table 57. Collegium Narcotic (Opioid) Drugs Product
Table 58. Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 59. Collegium Recent Development
Table 60. Johnson & Johnson Company Details
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Narcotic (Opioid) Drugs Product
Table 63. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Narcotic (Opioid) Drugs Product
Table 68. Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Mylan Company Details
Table 71. Mylan Business Overview
Table 72. Mylan Narcotic (Opioid) Drugs Product
Table 73. Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 74. Mylan Recent Development
Table 75. Hikma Pharmaceuticals Company Details
Table 76. Hikma Pharmaceuticals Business Overview
Table 77. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 78. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 79. Hikma Pharmaceuticals Recent Development
Table 80. Sun Pharma Company Details
Table 81. Sun Pharma Business Overview
Table 82. Sun Pharma Narcotic (Opioid) Drugs Product
Table 83. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 84. Sun Pharma Recent Development
Table 85. Endo Pharmaceuticals Company Details
Table 86. Endo Pharmaceuticals Business Overview
Table 87. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 88. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 89. Endo Pharmaceuticals Recent Development
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Narcotic (Opioid) Drugs Product
Table 93. Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million)
Table 94. Allergan Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Narcotic (Opioid) Drugs Product Picture
Figure 2. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Narcotic (Opioid) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Narcotic (Opioid) Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Narcotic (Opioid) Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Narcotic (Opioid) Drugs Market Share in Global 2017-2028
Figure 7. Narcotic (Opioid) Drugs Report Years Considered
Figure 8. Product Picture of Codeine
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Hydrocodone
Figure 11. Product Picture of Hydromorphone
Figure 12. Product Picture of Meperidine
Figure 13. Product Picture of Methadone
Figure 14. Product Picture of Others
Figure 15. Global Narcotic (Opioid) Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Narcotic (Opioid) Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 17. Global Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
Figure 18. United States Narcotic (Opioid) Drugs Market Share by Type in 2022 & 2028
Figure 19. United States Narcotic (Opioid) Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 20. United States Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
Figure 21. Product Picture of Pain Relief Application
Figure 22. Product Picture of Anesthesia Application
Figure 23. Global Narcotic (Opioid) Drugs Market Share by Application in 2022 & 2028
Figure 24. Global Narcotic (Opioid) Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
Figure 26. United States Narcotic (Opioid) Drugs Market Share by Application in 2022 & 2028
Figure 27. United States Narcotic (Opioid) Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
Figure 29. North America Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. United States Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. China Taiwan Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. UAE Narcotic (Opioid) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 57. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 58. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 59. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 60. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 61. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 62. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 63. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 64. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 65. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 66. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 68. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Keyplayers in Global and United States Narcotic (Opioid) Drugs Market Report & Forecast 2022-2028
PfizerTeva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
REQUEST TABLES & FIGURES MENTIONED IN THIS REPORT
